This is a serious brain condition that can happen in people with AIDS. It affects memory and thinking, making it hard to concentrate. People might also have trouble with their movements, like walking, and might need help with daily tasks like using the toilet. It's caused by the HIV virus affecting the brain.
Every report comes from a Lived member, sent anonymously.
Have you tried Highly Active Antiretroviral Therapy for HIV-Associated Dementia?
HIV-associated dementia is a decline in thinking, movement and behavior caused by the effects of HIV on the brain. Thinking typically becomes slower, and people have trouble paying attention, remembering new information, planning and switching between tasks. Movement can slow as well, showing up as a slower walk or less nimble hands, and changes in motivation, mood or social behavior are common. To count as dementia, these changes must be serious enough to interfere with work and everyday activities. It is the most severe form of a broader group called HIV-associated neurocognitive disorders. The milder forms, which cause measurable but smaller difficulties, are far more common. Dementia itself has become rare since effective HIV treatment arrived in the mid-1990s, and it now occurs mainly when HIV has gone undiagnosed or untreated and the immune system has been badly damaged. The condition was first described as AIDS dementia complex.
The cause is HIV itself. The virus reaches the brain early in infection and infects immune cells there, and the long-running inflammation that follows injures nerve cells. In dementia, that injury includes the loss of nerve cells, which is one reason some damage may not fully reverse even with treatment. The main risk is HIV that is not controlled. Risk is higher with a high amount of virus in the blood or spinal fluid, a low CD4 count (CD4 cells are the immune cells HIV destroys), especially a count that has ever fallen below 200, a long duration of infection, and missed doses or breaks in treatment. Older age, hepatitis C, heart and blood vessel disease, heavy alcohol or drug use (particularly methamphetamine and cocaine) and depression can add to thinking problems or make them worse. Dementia sometimes appears before other signs of AIDS, so it is not always a late event.
No single test confirms HIV-associated dementia. It is diagnosed by showing a clear decline in thinking that affects daily life, and then ruling out the many other conditions that can cause similar problems in someone with HIV. Assessment often begins with a few questions or a short screening test, such as whether someone has frequent memory lapses, feels slower when reasoning or planning, or has trouble paying attention. If screening suggests a problem, formal neuropsychological testing measures memory, attention, processing speed, planning and motor skills and compares the results with people of similar age and education. In dementia, scores fall well below the expected range in at least two areas. Blood tests look for conditions that can mimic it, such as syphilis, thyroid disease, vitamin B12 deficiency and kidney or electrolyte problems. A brain MRI is used mainly to exclude infections, tumors such as lymphoma, strokes and other causes; it often shows changes in the brain's white matter, but those changes are not specific to HIV. A spinal tap (lumbar puncture) can check for infections around the brain and, in someone already on treatment, whether HIV is still active in the spinal fluid and resistant to current medicines. Depression and medication side effects are also considered, because both can impair thinking. The diagnosis is not made during an acute illness, which can cloud thinking on its own.
Effective HIV treatment, called antiretroviral therapy (ART), is the foundation of care. ART is a combination of medicines that stops HIV from multiplying. Lowering the virus in the blood and in the fluid around the brain can improve thinking and movement, and some people improve substantially. For someone who has never been treated, starting ART is the most important step. For someone already on treatment, the care team checks whether the virus is truly suppressed, whether doses are being missed, and whether resistance testing points to a better combination. Because damage that has already happened may not fully reverse, earlier treatment may protect the brain more. Several other medicines have been tested specifically for HIV-related thinking problems, including memantine and rivastigmine (both used for Alzheimer's disease), stimulants and anti-inflammatory drugs. None has shown a clear benefit, so there is no proven medicine aimed at the dementia itself. Treating other contributors also matters: depression, sleep apnea, high blood pressure and other blood vessel risks, smoking, and alcohol or drug use. Some HIV medicines can affect mood, sleep or concentration (efavirenz is one example), so a review of every medicine is part of care. Occupational therapy and cognitive rehabilitation can teach practical strategies for memory, organization and daily tasks.
The course depends largely on how well HIV is controlled. Without treatment, HIV-associated dementia tends to worsen, and in its most advanced stage a person may lose bladder control and the ability to speak. With effective ART the outlook is very different: many people improve, and most people treated for HIV-related thinking problems stay at a fairly stable level rather than declining steadily. Recovery is often partial, and some slowness or memory difficulty may remain. In daily life, the effects show up in tasks that need speed, attention and planning: keeping up at work, managing money, following conversations and keeping track of appointments and medicines. That last point matters because missed doses of HIV medicines can let the virus rebound and worsen thinking further. Medication reminders, pill organizers and help from family or friends make it easier to stay on treatment. Depression and anxiety are common alongside these changes, and stigma can lead to isolation; counseling and support groups can help. Caregivers can face real strain and benefit from support of their own. Follow-up includes regular viral load and CD4 checks and periodic cognitive screening. As people with HIV live longer, age-related conditions such as blood vessel disease and Alzheimer's disease can also affect thinking, which is one reason ongoing assessment is useful.
Anyone with HIV who notices frequent memory lapses, feels slower when reasoning or planning, or has trouble paying attention should raise it at their next HIV visit and ask about cognitive screening. The same applies when family members notice changes, or when keeping up with medicines has become harder. Contact the care team promptly if thinking, alertness or walking gets noticeably worse over days to weeks, including in the first weeks after starting or changing HIV medicines, when a strong immune reaction can occasionally make brain symptoms worse. Because treated HIV-related impairment usually stays fairly stable, a quicker change suggests another cause, such as an infection, a medication effect or another illness, that needs its own treatment. Call 911 if fever comes with a severe headache, a stiff neck or new confusion, especially when HIV is not well controlled. These can be signs of meningitis or another brain infection, which can become life-threatening quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with HIV-Associated Dementia is like, what's helped you, or ask the community a question.